Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Alset AI Acquires Chaco Minerals Debenture Adding Approximately $1.3 Million Investment to Balance Sheet to Offset Lyken.AI Receivables and Strengthen Investment Portfolio
-
Quimbaya Gold Completes Tahami Center Exploration Targets; Cu-Mo-Au Porphyry System Confirmed Ahead of Q2 Drill Testing
-
Capstone Publishes Investor FAQ Detailing 72% Reduction in Convertible Principal and Reaffirming FY2026 Guidance
-
DocGo Announces Upcoming Participation at the 21st Annual Needham Technology, Media, & Consumer Conference
-
Most Oncology Brands Lose Before Launch Day — New ZoomRx Analysis of 40+ Drugs Quantifies the Awareness Gap That Predicts Commercial Failure
-
BuildCore taps multifamily powerhouse Cam Bruckman as Chief Revenue Officer
-
Glass House Brands Announces Application for DEA Registration of Certain Medical Operations
-
Medicus Pharma Announces Results from Pre-Specified Expanded Phase 2 SKNJCT-003 Data Analysis Demonstrating Positive Dose-Response
-
Holley Reports First Quarter 2026 Results
-
Bioventus Reports First Quarter Financial Results
-
Crescent Biopharma to Present at May Investor Conferences
-
Medline Reports First Quarter 2026 Results
-
Dragonfly Energy Selected for Additional Nevada Tech Hub Funding to Advance Battery R&D and Cell Development
-
Cronos Expands Pre-Roll Portfolio with Spinach STIX®
-
BriaCell Receives FDA Clearance to Initiate Bria-BRES+™ Clinical Study in Breast Cancer
-
StepStone Group to Announce Fourth Quarter and Fiscal 2026 Results on May 20, 2026
-
Applied Materials to Participate in Upcoming Investor Conferences
-
HNI Corporation Reports First Quarter 2026 Results
-
Abaxx Signs MoU to Support Development of Cambodian National Futures Exchange
-
Clean Harbors Announces First-Quarter 2026 Financial Results
-
Quantum Leap Energy Appoints Dr. Peter Fiske to Strategic Advisory Board
-
BTQ Technologies' QSSN Selected as Core Security Infrastructure for South Korea's First Bank-Led KRW Stablecoin Proof-of-Concept
-
CURE ALZHEIMER'S FUND PRESENTS THE 2026 JEFFREY L. MORBY PRIZE FOR EXCEPTIONAL RESEARCH
-
MakeMyTrip Limited to Report Fiscal 2026 Fourth Quarter and Full Year Financial & Operating Results on May 19, 2026
-
Stillwater Critical Minerals to Present at the Precious Metals & Critical Minerals Virtual Investor Conference May 7th
-
Tissue Dynamics and Galmed Pharmaceuticals to Develop Human-Centered Chronic Cardiac Fibrosis Platform to Advance Aramchol-Based Therapeutics
-
Award-Winning Habit Celebrates Newest Restaurant Launch in Eureka, California
-
Tradeweb Reports April 2026 Total Trading Volume of $62.2 Trillion and Average Daily Volume of $2.9 Trillion
-
Lucky Strike Entertainment Reports Third Quarter Results for Fiscal Year 2026
-
Altimmune to Report First Quarter 2026 Financial Results and Provide Business Update on May 13, 2026
-
DISCO Announces First Quarter 2026 Financial Results
-
Core Scientific Plans Expansion to 1.5 Gigawatts of Gross Power at Muskogee, Oklahoma Campus
-
Sentinel Capital Partners to Sell NSI Industries
-
908 Devices Reports First Quarter 2026 Financial Results and Raises 2026 Revenue Outlook
-
VenHub Highlights Rapid Progress Since Nasdaq Debut Including Expanded Smart Store Deployments, Enhanced Technology Platform and Increased Las Vegas Production Capacity
-
NVIDIA and Corning Announce Long-Term Partnership To Strengthen U.S. Manufacturing for AI Infrastructure
-
Elisa Expands PON Deployment with Vecima’s All-PON™ Shelf, Delivering 10G Fiber Services in Estonia
-
Zimmer Biomet to Present at the BofA Securities 2026 Health Care Conference
-
BEYONTTRA™ (acoramidis), the First Near-Complete TTR Stabilizer (≥90%), Approved by ANVISA to Treat ATTR-CM in Brazil
-
2026/27 SEASON OF SYMPHONY CENTER PRESENTS JAZZ PROGRAMMING ANNOUNCED
-
Immusoft to Present Data Highlighting Positive Results from the World’s First Engineered B Cell in a Human Clinical Trial at ASGCT 2026
-
Aramark Declares Quarterly Dividend
-
City Therapeutics Presents Preclinical Data on Next-Generation Investigational RNAi Therapy CITY-RBP4 for Treatment of Stargardt Disease at ARVO 2026 Annual Meeting
-
Uncountable Expands Specialty Chemicals Footprint with Four New Deals
-
Kura Oncology to Participate in Bank of America Securities Healthcare Conference
-
Sanborn Expands Geothermal Surveying Efforts to Support Cleaner Domestic Energy Development
-
REalloys (NASDAQ: ALOY) Receives Department of War Memorandum on Securing Domestic Heavy Rare Earth Supply Ahead of 2027 Deadline
-
QIMC Intersects 243 m Natural Hydrogen Zone Including 163 m Continuous Elevated Interval at West Advocate (DDH-26-03) - Strongest Response to Date
-
Ribo and Boehringer Ingelheim further progress their siRNA program for metabolic dysfunction-associated steatohepatitis (MASH)
-
Golfers Unite Announces Epic "Road Trip" to Celebrate the Game and Support A Non-Profit For Veterans

